News

 A new, very precise gene-editing tool created by Weill Cornell Medicine investigators will enable scientists to study the impact of these specific genetic changes in preclinical models rather than being limited to more broadly targeted tactics, such as deleting the entire gene.

Pregnant individuals who had a previous COVID-19 infection and received a full course of COVID-19 vaccination and a booster have the strongest immune protection from the disease – and pass that protection along to their unborn babies.

A non-opioid designer molecule for treating chronic neuropathic pain by calming hyperactive pain-sensing neurons in the peripheral nervous system has had promising results in a preclinical study.

While there are highly effective treatments for the hepatitis C virus (HCV), only 1 in 5 Medicaid enrollees diagnosed with HCV started treatment, according to a retrospective study led by researchers at Weill Cornell Medicine and Cornell University’s Ithaca campus. 

The award will enable Sarah Qureshy to take a year off from her schooling to carry out hematology research. 

Awards, honors and achievements for the month of July. 

Dr. Gregory F. Sonnenberg, The Henry R. Erle, M.D.-Roberts Family Associate Professor of Medicine and head of basic research in Gastroenterology and Hepatology at Weill Cornell Medicine, has been awarded a $3.26 million, five-year MERIT grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to investigate the underlying mechanisms of inflammatory bowel disease (IBD).

A multi-institutional team of scientists led by Dr. Mario Gaudino, the Stephen and Suzanne Weiss Professor in Cardiothoracic Surgery and assistant dean for clinical trials at Weill Cornell Medicine, has been approved for a nearly $30 million funding award from the Patient-Centered Outcomes Research Institute (PCORI). 

The availability of generic antiviral drugs to manage chronic hepatitis B resulted in significant savings to Medicare, despite an increase in prescriptions, according to an analysis by researchers at Weill Cornell Medicine and NewYork-Presbyterian.

During the COVID-19 pandemic, many U.S. hospitals had overcapacity intensive care units (ICU) while other area hospitals had open ICU beds available, a phenomenon known as “load imbalance.” The hospitals most likely to be overloaded in imbalanced regions served a higher number of Black patients and more patients enrolled in Medicaid, according to a new study conducted by Weill Cornell Medicine investigators.

Using an innovative method for measuring doctor turnover, Weill Cornell Medicine researchers determined that between 2010 and 2018, the annual rate at which physicians left their practices increased by 43 percent, from 5.3 percent to 7.6 percent a year.

Some women may excessively breastfeed and pump as a method of weight control, according to a new paper by investigators at Weill Cornell Medicine and Yale School of Medicine.

State laws allowing medical cannabis use did not reduce prescriptions for opioids or other therapies for chronic, non-cancer pain, according to a policy analysis by Weill Cornell Medicine investigators.

Dr. Greta Strong, an assistant professor of community outreach teaching in the Department of Neurology at Weill Cornell Medicine, received the U.S. Presidential Lifetime Achievement Award.

Awards, honors and achievements for the month of June. 

An atlas that catalogues gene activity and the levels of small molecules called metabolites in tumor samples offers a new way of identifying the deep mechanisms of cancer, according to researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.

Sara Mathew, associate director of research and operations administration in the Department of Surgery at Weill Cornell Medicine, has been selected as one of Crain’s Notable Leaders in Health Care.

The $9.8 million, five-year grant awarded to Weill Cornell Medicine and Columbia University will help combat cancer disparities fueled by persistent poverty.

A model for optimizing the dispensing of vaccines during pandemics that uses a new measure of success for such efforts has been developed by researchers at Weill Cornell Medicine, the Ithaca campus of Cornell University, Singapore University of Technology and Design and San Jose State University in California.

The program has prepared Weill Cornell Medicine faculty members to grow into institutional leaders.